The ability to regulate intrinsic membrane excitability, to maintain consistency of action potential firing, is critical for stable neural circuit activity. Without such mechanisms, Hebbian-based synaptic plasticity could push circuits toward activity saturation or, alternatively, quiescence. Although now well documented, the underlying molecular components of these homeostatic mechanisms remain poorly understood. Recent work in the fruit fly, Drosophila melanogaster, has identified Pumilio (Pum), a translational repressor, as an essential component of one such mechanism. In response to changing synaptic excitation, Pum regulates the translation of the voltagegated sodium conductance, leading to a concomitant adjustment in action potential firing. Although similar homeostatic mechanisms are operational in mammalian neurons, it is unknown whether Pum is similarly involved. In this study, we report that Pum2 is indeed central to the homeostatic mechanism regulating membrane excitability in rat visual cortical pyramidal neurons. Using RNA interference, we observed that loss of Pum2 leads to increased sodium current (I Na ) and action potential firing, mimicking the response by these neurons to being deprived of synaptic depolarization. In contrast, increased synaptic depolarization results in increased Pum2 expression and subsequent reduction in I Na and membrane excitability. We further show that Pum2 is able to directly bind the predominant voltage-gated sodium channel transcript (Na V 1.6) expressed in these neurons and, through doing so, regulates translation of this key determinant of membrane excitability. Together, our results show that Pum2 forms part of a homeostatic mechanism that matches membrane excitability to synaptic depolarization in mammalian neurons.
Introduction
Neuronal homeostasis enables neurons to adapt to changing synaptic excitation, to maintain consistency despite rapid turnover of ion channels and to compensate for perturbations in network activity. Without homeostasis, Hebbian-based changes in synaptic efficacy have the potential to destabilize circuit activity. Compensatory mechanisms operate to prevent this by maintaining membrane excitability within physiologically relevant limits (Turrigiano et al., 1994; Turrigiano, 1999) . Homeostatic mechanisms fall into two broad categories: synaptic and intrinsic. Synaptic mechanisms encompass the alteration of neurotransmitter release (Turrigiano and Nelson, 2004; Erickson and Spana, 2006) and/or postsynaptic receptor expression (Ehlers, 2003) . In contrast, neurons can alter their membrane excitability through intrinsic changes in expressed voltage-gated ion channels (Turrigiano and Nelson, 1998; Desai et al., 1999; Baines, 2003; Zhang and Linden, 2003; Marder and Goaillard, 2006) .
Most forms of intrinsic mechanisms involve changes in the relative density or functional properties of ion channels. A common target is the voltage-gated sodium channel (Na v ) (Desai et al., 1999; Mee et al., 2004; Muraro et al., 2008) . Sodium channels are critical for the generation of action potentials, and alterations in their density can change action potential threshold (Catterall et al., 2005; Kole et al., 2008) . Our work in Drosophila shows that changes in synaptic depolarization of motoneurons are compensated for by altered membrane excitability, primarily mediated through a change in sodium current (I Na ) density Baines, 2003; Mee et al., 2004; Muraro et al., 2008) . This change requires Pumilio (Pum), a known translational repressor (Tautz, 1988; Wharton and Struhl, 1991; Wharton et al., 1998) . The Drosophila model is consistent with activity-dependent change in Pum acting to regulate translation of the sole Na v (termed paralytic) in this insect. As synaptic depolarization increases, so does the activity of Pum, which, through binding to conserved domains [Nanos response elements (NREs)] in the Na v transcript, suppress translation (Muraro et al., 2008) . This reduces I Na and action potential firing.
Mammalian cortical neurons similarly exhibit intrinsic homeostatic regulation of I Na (Desai et al., 1999) , and Pum2 expression is activity dependent in cultured hippocampal neurons (Vessey et al., 2006) . Alignment of mouse Pum1 and Pum2 proteins with their Drosophila homolog show 51 and 55% overall similarity, which further increases to 86 and 88% in the RNAbinding domains (Spassov and Jurecic, 2002) . Pum2 has been reported to bind rat Na v 1.1 transcript (Vessey et al., 2010). However, whether Pum2 regulates membrane excitability in mamma-lian neurons in an activity-dependent manner, akin to that observed in Drosophila, is unknown.
We show here that cultured rat cortical pyramidal neurons regulate both I Na and action potential firing in response to changing synaptic depolarization. Activity also affects the expression of Pum2, and, moreover, manipulation of Pum2 is sufficient to alter I Na and action potential firing. We further show that Pum2 directly binds Na V 1.6 mRNA, which is the principal Na v expressed in these neurons. We conclude that Pum2 is an essential component of the homeostatic mechanism that allows neurons to regulate intrinsic excitability to adapt to changes in synaptic depolarization.
Materials and Methods
Cell culture and transfection. Visual cortical neurons were isolated from 3-d-old (P3) Sprague Dawley rat pups of either sex. Pups were killed by decapitation. All experiments were conducted in accordance with the United Kingdom Animals Scientific Procedures Act (1986) and institutional regulations. The visual cortex was removed and placed in ice-cold ACSF buffer (in mM: 126 NaCl, 3 KCl, 2 MgSO 4 .7H 2 O, 1 NaH 2 PO 4 .2H 2 O, 25 NaHCO 3 , 2 CaCl 2 , and 14 dextrose, pH 7.4), sliced into 500-m-thick sections, and incubated in 20 U/ml papain (Worthington Biochemical) in Earle's balanced salt solution (1.8 mM calcium EBSS supplemented with 10 mM dextrose) for 90 min at 37°C in a 5% CO 2 humidified incubator. After digestion, tissue was resuspended in weak protease inhibitor (1 mg/ml of both BSA and trypsin inhibitor in EBSS) and an equal amount of strong inhibitor solution (10 mg/ml of both BSA and trypsin inhibitor in EBSS) was added. The tissue was triturated with a firepolished Pasteur glass pipette. After any remaining tissue had settled, the supernatant was removed and filtered through a 70 m mesh (Falcon; BD Biosciences Discovery Labware) and centrifuged at 1000 ϫ g for 5 min at room temperature. Dissociated cells were resuspended in MEM cell culture medium (supplemented with 5% FBS, 2 mM L-glutamine, 50,000 U/50 mg penicillin-streptomycin, 1ϫ B27 supplement, and 33 mM dextrose) and plated onto poly-D-lysine (0.5 mg/ml; Sigma) and collagen-1 (0.782 mg/ml; rat tail collagen; BD Biosciences) coated 22 ϫ 22 mm glass coverslips at a density of 1.5 ϫ 10 5 cells/ml. One-third of the media was refreshed every 2 d.
To assess the role of Pum2, cortical neurons were transfected with an RNA interference (shRNA) plasmid (also encoding a GFP reporter) against Pum2 or empty pSUPERIOR-GFP as control using the calcium phosphate precipitation technique after 7-9 d in culture as described by Vessey et al. (2010) . Plasmid DNA (3 g) was added to freshly diluted CaCl 2 solution (250 mM), and the total volume of both solutions was 60 l. An equal amount of 2ϫ 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid (BES) buffer (in mM: 50 BES, 1.5 Na 2 HPO 4 , and 280 NaCl 2 , pH 7.2) was added in a dropwise manner to the DNA/CaCl 2 solution. The DNA/calcium phosphate solution was immediately added dropwise to the neurons growing in 3 cm Petri dishes containing 2 ml of prewarmed transfection medium (MEM supplemented with 1 mM sodium pyruvate, 15 mM HEPES, 2 mM L-glutamate, 1ϫ B27 supplement, and 33 mM dextrose), followed by gentle swirling. Neurons were incubated at 37°C in 5% CO 2 for 40 min to allow the DNA/calcium phosphate coprecipitate to form. Neurons were washed with prewarmed HBSS buffer (in mM: 135 NaCl 2 , 20 HEPES, 4 KCl, 1 Na 2 HPO 4 , 2 CaCl 2 , 1 MgCl 2 , and 10 glucose, pH 7.3) for 5 min to remove the DNA/calcium phosphate coprecipitate. Transfected cortical neurons were maintained in culture medium for an additional 2-3 d.
Electrophysiology. Cortical neurons were visualized at 40ϫ with differential interference contrast optics, and transfection was confirmed by GFP expression. Patch-clamp recordings were obtained using thickwalled borosilicate glass electrodes (GC100F-10; Harvard Apparatus) with resistance between 3 and 5 M⍀. Pyramidal neurons were identified by shape and large soma size. Recordings were made using a Multiclamp 700A amplifier controlled by pClamp 10.2 (Molecular Devices). To better resolve I Na , an online leak subtraction protocol was used (P/4). Traces were filtered at 10 kHz (Bessel) and digitized at 20 kHz.
Whole-cell voltage clamp was used to isolate I Na . Cells were exposed to an extracellular solution containing the following (in mM): 33 NaCl, 97 choline chloride, 3 KCl, 2 MgCl 2 , 20 HEPES, 1.6 CaCl 2 , 0.4 CdCl 2 , 10 tetraethylammonium chloride, 5 4-aminopyridine, and 14 dextrose, pH 7.4. Internal patch solution contained the following (in mM): 120 CsMeSO 4 , 10 KCl, 10 HEPES, 10 EGTA, and 3 ATP disodium salt, pH 7.3. To activate voltage-gated sodium channels, neurons were stepped from a holding potential of Ϫ60 to ϩ30 mV in 5 mV increments for 50 ms from a prepulse of Ϫ90 mV (100 ms). Each neuron was subjected to three separate activation protocols, and an average was generated. Current density was obtained by normalizing to cell capacitance (69.14 Ϯ 5.79 vs 63.62 Ϯ 5.61 vs 70.03 Ϯ 8.69 pF, control vs activitydeprived, n ϭ 26 and 21, p ϭ 0.61, control vs activity-enhanced, n ϭ 26 and 19, p ϭ 0.10). Current-voltage plots shown are averages derived from three separate cultures with a minimum of eight recordings from each individual culture.
Whole-cell current-clamp recordings were performed using external saline containing the following (in mM): 126 NaCl, 3 KCl, 2 MgSO 4 .7H 2 O, 1 NaH 2 PO 4 .2H 2 O, 25 NaHCO 3 , 2 CaCl 2 , and 14 dextrose, pH 7.4 (maintained by bubbling continuously with 5% CO 2 / 95% O 2 ). Internal patch solution used contained the following (in mM): 130 KMeSO 4 , 10 KCl, 10 HEPES, 2 MgSO 4 .7H 2 O, 0.5 EGTA, and 3 ATP disodium salt, pH 7.3. After breakthrough, neurons were held at Ϫ60 mV by injection of constant current. Current injections of Ϫ20 to ϩ200 pA in 20 pA increments were applied for 500 ms. For each neuron, this protocol was repeated twice, and the number of action potentials fired at each step was averaged. Input-output curves shown are averages derived from at least two separate cultures with a minimum of eight recordings from each individual culture.
Manipulation of synaptic activity and Pum2 silencing. For chronic block of excitatory (mediated by glutamate) or inhibitory (mediated by GABA) synaptic currents, NBQX/AP-5 (20 and 50 M, respectively) or gabazine (40 M SR95531) were added to cell cultures on day 7 (drugs from Abcam). After 24 h, a third of the media was exchanged and drugs were refreshed. Cultures were maintained for an additional 24 h. Drugs were washed out before recordings. For experiments to assess the role of Pum2, cortical neurons were transfected with plasmids to express either shRNA against Pum2 (also containing GFP) or empty pSUPERIOR-GFP as a control, as described above. When transfection and antagonists were used in combination, neurons were transfected and incubated overnight and then treated with drugs for 2 d, as detailed above.
RT-PCR from whole tissue. P3 rat visual cortex was homogenized, RNA was extracted using an RNeasy Plus Micro Kit (Qiagen) following the instructions of the manufacturer, and cDNA was synthesized using the Revert Aid H Minus first-strand cDNA synthesis kit (Fermentas Life Sciences). The procedure used was as follows. Briefly, 1 l of 25 ng/l cDNA samples were amplified for 35 cycles in the presence of individual sets of primer pairs (Table 1) . To detect product, 5 l of amplified cDNA was separated by 2% agarose gel electrophoresis, visualized by ethidium bromide (1 g/ml) under ultraviolet light. The PCR product was excised from the agarose gel after electrophoresis and purified using the QIAquick Gel Extraction Kit (Qiagen). The PCR product was sequenced using Big Dye Terminator Version 3.1 Chemistry and the primers described in Table 1 , and run on an ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems).
RT-PCR from pyramidal neurons. In whole-cell configuration, gentle suction was applied to aspirate the cytoplasm without disrupting the seal. The tip of the electrode containing the aspirated cell content was broken off in a 0.2 ml PCR tube containing RNase inhibitor and RNA-free water in a 1:4 ratio (5 l total volume). cDNA (from 10 cells per sample) was synthesized using the Revert Aid H Minus first-strand cDNA synthesis kit (Fermentas Life Sciences). The synthesized cDNA was amplified using BIOTAQ DNA polymerase (Bioline). Controls were performed by placing patch pipettes next to transfected cells and using gentle suction to draw off a small amount of extracellular media. A two-stage PCR amplification was used: briefly, one-sixth of the cDNA product was amplified for 45 cycles in the presence of six Na v primers ( Table 1 ). The thermal cycling protocol was 2 min at 94°C, 45 cycles at 15 s at 94°C, 30 s at 48°C, and finally 50 s at 72°C, followed by a 10 min final extension. In the second-stage PCR, 1 l of the first-stage PCR amplification was used as template, and an individual set of primer pairs were run for 40 cycles (for primers used, see Table 1 ).
Immunocytochemistry. Neurons were washed in PBS (in mM: 137 NaCl, 2.7 KCl, 8 Na 2 HPO 4 , and 1.46 KH 2 PO 4 , pH 7.4) and fixed in 4% paraformaldehyde for 15 min at room temperature. Neurons were permeabilized for 30 min in PBS containing 100 mM glycine, 1% BSA, and 0.2% Triton X-100 and then blocked for 1 h in PBS containing 300 mM glycine, 3% BSA, and 0.2% Triton X-100 at room temperature. The primary antibodies used were anti-Na V 1.6 (1:50; Alamone Labs), antiPum2 antibody (1:200; Abcam), and anti-microtubule-associated protein 2 antibody (1:1000; Sigma) diluted in PBS containing 10% normal goat serum and 0.2% Triton X-100 and incubated overnight at 4°C. Neurons were washed and incubated in Alexa Fluor 568 goat anti-rabbit IgG antibody (1:500; Molecular Devices, Invitrogen) and Alexa Fluor 488 goat anti-mouse IgG antibody (1:2000; Molecular Devices, Invitrogen) for 1 h at room temperature. Neurons were washed and mounted in Vectashield HardSet Mounting Medium (Vector Laboratories), and images were captured using a Leica DM6000B microscope. Captured Z-stacks were deconvolved, and soma fluorescence was measured using a circular region of interest tool in Image Pro 7 (Media Cybernetics). Fluorescent intensity data presented are corrected for both soma area (by dividing pixel intensity by area) and background values (by subtraction).
Immunoprecipitation. P3 rat brain was homogenized in ice-cold lysis buffer [25 mM HEPES, 150 mM KCl, 20 mM MgCl 2 , 8% (v/v) glycerol, 0.1% (v/v) Nonidet P-40, 1 mM DTT, RNase inhibitor (1 U/l; Thermo Fisher Scientific), and protease inhibitor (1:100; Sigma), pH 7.4]. Lysate was maintained at 4°C for 2 h with constant agitation and centrifuged for 20 min at 12,000 ϫ g at 4°C, and supernatant was collected. Lysate was precleared using goat serum (50 l/ml; Sigma) incubated for 1 h at 4°C with constant agitation, and 100 l of Protein A Sepharose (100 l/ml; GE Healthcare, Buckinghamshire, UK) was added and gently mixed for 1 h at 4°C. Lysate was centrifuged for 20 s at 12,000 ϫ g, and supernatant was collected. Affinity-purified anti-Pum2 antibody (5 g/mg; Abcam) or anti-pan-sodium channel antibody (6 g/mg; Alamone Labs) was added to precleared lysate and incubated for 1 h at 4°C with constant agitation. Protein A Sepharose (200 l/ml) was added and gently mixed for 1 h at 4°C. Lysate was centrifuged for 20 s at 12,000 ϫ g, and the pellet was saved. Pellet was washed three times with fresh ice-cold lysis buffer, after each wash, the lysate was centrifuged for 20 s at 12,000 ϫ g, and supernatant was discarded.
To isolate total RNA, the pellet was treated with TRIzol (Invitrogen) following the instructions of the manufacturer, and cDNA was synthesized using the Revert Aid H Minus first-strand cDNA synthesis kit (Fermentas Life Sciences). The synthesized cDNA was amplified in a two-stage PCR amplification as described previously.
Statistics. Statistical significance was calculated using a one-way ANOVA (with Bonferroni's post hoc comparison test) unless noted otherwise. Significance levels of *p Յ 0.05 or **p Յ 0.01 are shown.
Results

Activity blockade increases intrinsic excitability
Cortical pyramidal neurons deprived of synaptic excitation respond by lowering their threshold for action potential firing (Desai et al., 1999) . This change in intrinsic excitability allows neurons to maintain consistency in firing when exposed to chronic changes in synaptic depolarization. However, although well documented, the underlying mechanism of this homeostatic response has not been fully investigated.
To determine the effects of chronic changes in activity on intrinsic electrical properties, we treated our pyramidal cell cultures for 48 h with either blockers of excitatory synaptic activity ("activity-deprived," NBQX/AP-5 at 20 and 50 M, respectively) or blockers of inhibitory synaptic signaling ("activity-enhanced," gabazine at 40 M). After washout of blockers, we used currentclamp recordings to determine input-output curves for action potential firing. Resting membrane potential, on breakthrough, was Ϫ46.0 Ϯ 2.2, Ϫ33.8 Ϯ 2.8, and Ϫ33.2 Ϯ 3.5 mV (control vs activity-deprived vs activity-enhanced, p ϭ 0.01 for activity manipulations compared with control but p Ͼ 0.05 for activitydeprived vs enhanced, n Ն 8, means Ϯ SEM). Hyperpolarizing constant current was injected to hold V m at Ϫ60 mV, a level at which all recorded cells were silent. Current injections were applied to depolarize cells to evoke action potential firing. Chronic activity deprivation (NBQX/AP-5) resulted in increased action potential firing compared with controls ( Fig. 1A) . At current amplitudes above 20 pA, the average frequency of firing was significantly greater than the average control frequency ( p ϭ 9.92 ϫ 10 Ϫ4 ; Fig. 1B ). In contrast, exposure to enhanced excitation (gabazine) resulted in decreased action potential firing (Fig. 1A) . At each current amplitude above 80 pA, the average frequency of firing was significantly decreased compared with control ( p ϭ 0.05; Fig. 1B ). Threshold for action potential firing compared with control did not differ significantly in either treatment (Ϫ35.3 Ϯ 1.7 vs Ϫ30.5 Ϯ 2.1 vs Ϫ41.7 Ϯ 2.3 mV; control vs activity-deprived vs activity-enhanced, p Ͼ 0.05 vs control, n Ն 8, means Ϯ SEM). However, threshold was significantly different between the two activity manipulations ( p ϭ 0.002 activitydeprived vs activity-enhanced). Input resistance did not change (690 Ϯ 70, 730 Ϯ 90, and 790 Ϯ 130 M⍀, control vs activitydeprived, n ϭ 20 and 16, p ϭ 0.95; control vs activity-enhanced, n ϭ 20 and 14, p ϭ 0.76). Thus, we conclude that deprivation of synaptic excitation results in increased action potential firing and vice versa.
Under voltage clamp, we observed that the average amplitude of I Na was significantly increased after chronic activity deprivation ( Fig. 2A) . On average, activity deprivation increased peak I Na by ϳ30% (Ϫ44.7 Ϯ 4.1 vs Ϫ34.5 Ϯ 2.0 pA/pF, deprived vs control, n ϭ 42 and 22, p ϭ 0.02; Fig. 2B ). As predicted, exposure to enhanced excitation (gabazine) reduced the amplitude of I Na (Ϫ34.5 Ϯ 2.0 vs Ϫ15.7 Ϯ 2.2 pA/pF, control vs enhanced, n ϭ 42 and 20, p ϭ 1.66 ϫ 10 Ϫ5 ; Fig. 2 A, B) . These observations, which confirm a previous report (Desai et al., 1999) , show that the homeostatic response to changing levels of synaptic input is mediated, at least in part, by reciprocal change in I Na . However, it is important to note that, in addition to I Na , Desai et al. show that K ϩ conductances are also affected, and it is likely that these combined changes account for the alteration to membrane excitability. Pum2 regulates intrinsic excitability in response to altered synaptic excitation To establish whether Pum2 expression is altered after chronic block of either synaptic excitation (NBQX/AP-5) or inhibition (gabazine), we quantified Pum2 protein expression levels in pyramidal neurons under these conditions. To do this, we used immunofluorescence with an antibody to Pum2 (see Materials and Methods). Pum2 fluorescence intensity was significantly decreased in chronically activity-deprived neurons compared with control neurons (ϳ44%: 8065.5 Ϯ 274.6 vs 14,499.6 Ϯ 1145.4 pixel intensity units, deprived vs control, n ϭ 25 and 59, p ϭ 6.14 ϫ 10 Ϫ12 ; Fig. 3 A, B) . In comparison, in cultures in which synaptic excitation was increased (gabazine), the average Pum2 fluorescence intensity was significantly increased (ϳ58%: 16,606.7 Ϯ 702.2 vs 10,462.9 Ϯ 866.9 pixel intensity units, depolarized vs control, n ϭ 60 and 55, p ϭ 1.09 ϫ 10 Ϫ25 ; Fig. 3 A, B) . Control values are normalized to 1.0 in Figure 3B .
These data show that activity deprivation, which results in increased I Na and action potential firing, is associated with a decrease in levels of Pum2 and vice versa. This is consistent with a model derived from Drosophila in which a reduction in Pum is associated with increased I Na ( 
2008
). To directly demonstrate that reduced Pum2 is sufficient to increase both I Na and action potential firing, we used RNA interference (shRNA). Pum2 immunofluorescence intensity was significantly decreased in cells transfected with shRNA-Pum2, indicative of effective knockdown (control, 17,053.0 Ϯ 1132.8 vs shRNA-Pum2, 7699.5 Ϯ 406.8, n ϭ 21 and 20, p ϭ 3.04 ϫ 10 Ϫ10 , t test). As expected, after transfection of pyramidal neurons with shRNA against Pum2, we observed a significant increase in action potential firing. At each current step above 20 pA, the average frequency of firing was significantly increased compared with control neurons transfected with an empty pSUPERIOR-GFP vector ( p ϭ 0.003, t test; Fig. 4 A, B) . We also observed a significant increase in I Na in shRNAtreated cells (Ϫ68.2 Ϯ 5.3 vs Ϫ31.6 Ϯ 1.9 pA/pF, shRNA vs control, n ϭ 40 and 70, p ϭ 5.89 ϫ 10 Ϫ12 , t test; Fig. 4C ,D). These observations are consistent with Pum2 being sufficient to regulate both action potential firing and I Na in response to changing synaptic excitation in pyramidal cells. We also attempted to overexpress Pum2 in our cultures, but cell viability was affected to the extent that it was not possible to obtain adequate patch recordings for analysis.
Our results show that reducing Pum2 recapitulates the effect of activity deprivation, with both treatments increasing I Na and action potential firing. This suggests that Pum2 participates in the homeostatic mechanism triggered by activity deprivation. To confirm this, we adopted two approaches. First, we determined whether the change in membrane excitability mediated by activity deprivation (i.e., exposure to NBQX and AP-5) and Pum2 knockdown are synergistic. The two treatments would not be expected to show synergy if activity mediates its effect through a pathway involving Pum2. Our second approach combined Pum2-shRNA knockdown with chronic enhancement of synaptic activity (i.e., exposure to gabazine). We reasoned that, if enhanced activity results in reduced I Na through increased Pum2, then this combination should prevent change to I Na. We focused our attention on I Na for this analysis, but it is inferred that any increase in I Na leads to a concomitant increase in action potential firing (Mee et al., 2004; Muraro et al., 2008) . Two-way ANOVA revealed significant effects of activity (F (2,248) ϭ 23.8, p ϭ 1.52 ϫ 10 Ϫ8 ) and Pum2 (F (1,248) ϭ 61.5, p ϭ 2.48 ϫ 10 Ϫ11 ) and a significant interaction between activity and Pum2 (F (2,248) ϭ 4.0, p ϭ 0.02). The data were further analyzed with a post hoc Bonferroni's test. The increase in peak I Na after reduction in Pum2 levels (by shRNA) is greater than that observed after chronic blockade of activity. However, synergy was not observed when both treatments were combined (control, 31.6 Ϯ 1.2 pA/pF; activity block, 44.7 Ϯ 4.1 pA/pF; shRNAPum2, 68.3 Ϯ 5.3 pA/pF; combined, 65.2 Ϯ 4.3 pA/pF, n ϭ 80, 22, 40, and 45; control vs activity deprived, p ϭ 0.04; control vs shRNA, p ϭ 1.53 ϫ 10 Ϫ18 ; shRNA vs combined p ϭ 0.97; Fig.  5A ). In contrast, chronic enhancement of activity results in a significant decrease in peak I Na . However, when combined with Pum2 shRNA, we observed no significant change in peak I Na compared with controls (pSUPERIOR transfected, no drug treatment, control, 31.6 Ϯ 1.2; activity enhanced, 15.7 Ϯ 2.2; shRNAPum2, 68.3 Ϯ 5.3; combined, 35.4 Ϯ 4.5 pA/pF, n ϭ 80, 20, 40, and 17, respectively; control vs activity enhanced, p ϭ 0.01; control vs combined, p ϭ 0.99; Fig. 5A ). This supports our hypothesis that Pum2 is required for activity-induced change in I Na . Together, these two observations are also supportive of the model in which activity regulates membrane excitability through alteration of Pum2 level.
To further confirm that these alterations in excitability were the result of changing Pum2 expression levels, we performed immunocytochemistry. Two-way ANOVA showed significant effects of activity (F (2,276) ϭ 31.9, p ϭ 3.52 ϫ 10 Ϫ3 ) and Pum2 (F (1,276) ϭ 70.2, p ϭ 2.78 ϫ 10 Ϫ15 ) and a significant interaction between activity and Pum2 (F (2,276) ϭ 13.9, p ϭ 1.78 ϫ 10 Ϫ6 ). Post hoc Bonferroni's testing revealed that Pum2 immunofluorescence intensity was significantly decreased in neurons transfected with shRNA-Pum2 and when combined with activity deprivation (control, 17,053.0 Ϯ 1132.8 pixel intensity units; shRNA-Pum2, 7699.5 Ϯ 406.8 pixel intensity units; combined, 8366.0 Ϯ 691.6 pixel intensity units, n ϭ 21, 20, and 21, respectively; control vs shRNA, p ϭ 3.71 ϫ 10 Ϫ8 ; control vs combined, p ϭ 7.01 ϫ 10 Ϫ7 ; Fig. 5B ). However, when both treatments were combined, Pum2 immunofluorescence intensity was not significantly different, further showing that the effects of both are not synergistic ( p ϭ 0.99, shRNA vs combined). In contrast, chronic enhancement of activity (gabazine) results in a significant increase in Pum2 immunofluorescence intensity. When activity enhancement was combined with shRNA-Pum2 transfection, we observed no significant change in Pum2 immunofluorescence intensity compared with control levels (control, 17,053.0 Ϯ 1132.5 pixel intensity units; shRNA-Pum2, 7699.5 Ϯ 406.8 pixel intensity units; combined, 11,999.3 Ϯ 1002.3 pixel intensity units, n ϭ 21, 20, and 12, respectively; control vs shRNA, p ϭ 3.71 ϫ 10 Ϫ8 ; control vs combined, p ϭ 0.20; Fig. 5B ). Controls are normalized to 1.0 in Figure 5B . Finally, plotting peak I Na versus Pum2 immunofluorescence intensity shows a linear and inverse relationship across a range of manipulations, consistent with, and supportive of, Pum2 directly regulating I Na density (Fig. 5C) . A caveat to interpretation of immunocytochemistry is the qualitative aspect of the analysis of staining intensity. However, when considered together with our quantitative voltageclamp data, these results suggest that Pum2 is not only sufficient, but also necessary, for activity-dependent regulation of membrane excitability in cortical pyramidal neurons. mammalian brain expresses several different Na v s, and we were interested to test which ones may be targeted by Pum2. To do so, we first established the pattern of Na V subtype expression in cortical pyramidal neurons used for our recordings. Using RT-PCR, we observed robust expression of Na V 1.1, Na V 1.2, Na V 1.3, and Na V 1.6 mRNA in visual cortex (Fig.  6A) . In contrast, we could only detect Na V 1.6 expression in cortical pyramidal neurons (Fig. 6B) . To establish whether Pum2 could potentially bind Na V 1.6 mRNA, we performed a bioinformatic search using two sequences; the Pumilio regulatory element (PRE; UGUAAAUA) and the NRE (GUUGU) (Murata and Wharton, 1995; . This search revealed one exact match to the PRE and several matches for the NRE in the open reading frame (ORF) of Na V 1.6 (H.E.D. and R.A.B., unpublished results). To experimentally show whether Pum2 directly binds Na v 1.6 mRNA, we immunoprecipitated Pum2 using an affinitypurified Pum2 antibody, from whole-brain lysate and subjected the eluted RNA to RT-PCR to test for the presence of Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.5, Na V 1.6, and Na V 1.8. Our pull-down clearly showed that Pum2 associates with only Na v 1.6 (Fig. 6C) . We did not observe any other Na v s in our pull-downs, although it has been reported that Pum2 binds to Na v 1.1 from rat brain lysates (Vessey et al., 2010) . Control pulldowns, using a pan-Na v antibody, did not immunoprecipitate any Na v transcripts.
Pum2 binds
To confirm that Na v 1.6 is a target of activity-dependent regulation in cortical pyramidal neurons, we determined whether Na V 1.6 expression is altered after chronic block of either synaptic excitation (NBQX/ AP-5) or inhibition (gabazine). To do so, we deprivation and reduced expression of Pum2 (shRNA) on I Na are not synergistic. The reduction in I Na after activity enhancement is prevented by combining this treatment with Pum2 shRNA. Data shown are means Ϯ SEM, n Ն 17. *p Յ 0.05 and **p Յ 0.01 relative to control values (Bonferroni's post hoc test after a two-way ANOVA). B, Pum2 immunofluorescence intensity (measured in the cell body) of cortical pyramidal neurons also shows that the reduction in expression seen with activity deprivation or Pum2 shRNA are not synergistic in combination. Simultaneous reduction of Pum2 levels (shRNA) prevents the large increase observed in immunofluorescence attributable to activity enhancement. Data shown are means Ϯ SEM, n Ն 12. **p Յ 0.01 relative to control values (Bonferroni's post hoc test after a two-way ANOVA). C, Peak I Na is inversely proportional to Pum2 immunofluorescence intensity indicative of a correlation between the two (weighted total least squares, r ϭ 0.93). 1, Control; 2, activity deprived; 3, shRNA-Pum2; 4, shRNA-Pum2/activity deprived; 5, activity enhanced; and 6, shRNA-Pum2/activity enhanced.
used an Na v 1.6-specific antibody coupled to immunofluorescence. The averaged Na V 1.6 immunofluorescence signal intensity was significantly increased in activity-deprived neurons compared with control, nontreated neurons (ϳ25%: 21,589.9 Ϯ 789.0 vs 17,217.1 Ϯ 607.8 pixel intensity units, deprived vs control, n ϭ 24 and 32, p ϭ 4.44 ϫ 10
Ϫ5
; Fig. 6D,E) . In contrast, in cultures in which neurons were exposed to enhanced synaptic activity (gabazine), Na V 1.6 fluorescence intensity was decreased compared with control, nontreated neurons (ϳ22%: 14,163.3 Ϯ 457.1 vs 17,217.1 Ϯ 607.8 pixel intensity units, enhanced vs control, n ϭ 24 and 32, p ϭ 0.007; Fig. 6D,E) . Controls are normalized to 1.0 in Figure 6E . These results are entirely consistent with, and supportive of, a model in which activity-dependent change in Pum2 regulates membrane excitability through translational repression of Na v 1.6.
Discussion
Homeostasis acts to stabilize network activity in response to Hebbian-based synaptic plasticity (Turrigiano et al., 1994; Turrigiano, 1999) . Our previous work exploited the powerful genetics of Drosophila to identify the requirement for Pum, a translational repressor, for homeostatic control of membrane excitability in motoneurons. Pum regulates neuronal excitability by directly binding to and repressing translation of DmNa v mRNA that encodes the I Na in this insect (Mee et al., 2004; Muraro et al., 2008) . Although it has long been appreciated that mammalian neurons also exhibit this type of homeostatic regulation (Desai et al., 1999) , the underlying regulatory mechanism was not known. Here we show that, in cortical pyramidal neurons, I Na changes in an activity-dependent manner, as has been reported previously. Notably, we have investigated the mechanism of this homeostatic regulation and convincingly show that the changes in I Na and hence, in action potential firing, are mediated by Pum2. This strongly suggests that the function of Pum is evolutionarily conserved: Drosophila and rat diverged at least 60 million years ago. It also suggests that homeostatic regulation via Pum occupies a predominant role in maintaining stable circuit activity in all nervous systems.
Unlike the relative simplicity of Drosophila, which expresses only a single characterized voltage-gated sodium channel gene ( paralytic), it is perhaps more challenging to fully appreciate how Pum2 may regulate I Na in a mammalian nervous system that expresses multiple sodium channel encoding genes. The mammalian genome encodes a family of 10 voltagegated sodium ␣-subunits, Na V 1.1-Na v 1.9, and an atypical sodium channel termed Na V X (Yu and Catterall, 2004) . Within the CNS, Na V 1.1, Na V 1.2, Na V 1.3, and Na V 1.6, encoded by the scn1A, scn2A, scn3A, and scn8A genes, are the primary sodium channels (Catterall, 2000; Goldin et al., 2000; Goldin, 2001; Trimmer and Rhodes, 2004) . We observed expression of all typical CNS Na V s (1.1, 1.2, 1.3 , and 1.6) in visual cortex from . Pum2 binds Na V 1.6 mRNA and decreases Na V 1.6 expression. A, PCR from visual cortex shows the presence of Na V 1.1 (faint band), Na V 1.2, Na V 1.3, and Na V 1.6 mRNA. B, PCR from pooled pyramidal neurons shows only Na V 1.6 mRNA. C, Immunoprecipitation using Pum2 antibodies (Pum2 IP) was sufficient to pull down Na V 1.6 mRNA. In contrast, immunoprecipitation using a pan-Na v antibody (Na v IP) did not pull down any Na v transcripts. A lysate of visual cortex is also shown (Vis. cortex, far left lane) that was not subjected to immunoprecipitation. D, Immunofluorescence of cortical pyramidal neurons stained with Na v 1.6 antibody shows an increase in signal intensity in activity-deprived neurons(middle image) and a decrease in activity-enhanced neurons (right image) compared with controls (left image). Scale bar, 50 m. E, Averaged data show that activity deprivation increases antibody-specific Na v 1.6 immunofluorescence by 25% and activity enhancement decreases immunofluorescence by 22%. Immunofluorescence intensity measurements (measured at the cell body) were performed at the same time and are normalized for cell surface area (for details, see Materials and Methods). Data shown are means Ϯ SEM, n Ն 24. *p Յ 0.05, **p Յ 0.01 (one-way ANOVA with Bonferroni's post hoc comparison test).
which our cultures are derived. However, PCR from the pyramidal neurons from which we record showed that Na V 1.6 expression predominates. It is well known that Na V 1.6 is the most abundant Na V in the output neurons of the cerebellum, cerebral cortex, and hippocampus (Savio-Galimberti et al., 2012) . In the CA1 region of hippocampus, Na V 1.6 is also the dominant Na V in the axon initial segments (AIS) and nodes of Ranvier of the pyramidal neurons, with Na V 1.2 observed in the proximal part of the AISs (Westenbroek et al., 1989; Krzemien et al., 2000; Lorincz and Nusser, 2010) . Pum2 is also widely expressed in mammalian brain (Vessey et al., 2010) , indicating that the homeostatic mechanism we report is also likely to be operative in many other brain regions.
In Drosophila, Pum function is perhaps best understood from the viewpoint of the establishment of the embryonic anteriorposterior axis involving the translational repression of hunchback transcript (Murata and Wharton, 1995) . In recent years, Pum has also been reported to be required for normal CNS function, including memory formation (Dubnau et al., 2003) , neuron dendrite morphology (Menon et al., 2004; Ye et al., 2004) , and glutamate receptor expression in muscle (Menon et al., 2009 ). In addition to our own previous work showing that Pum is able to regulate I Na in Drosophila motoneurons (Mee et al., 2004) , these and other observations collectively provide an important mechanistic understanding of Pum. Thus, studies in yeast, Dictyostelium, Caenorhabditis elegans, Drosophila, and Xenopus show that Pum proteins are sequence-specific RNA-binding proteins capable of recognizing specific nucleotide sequences in the target mRNAs often, but not always, localized to the 3Ј untranslated region (UTR) (Kennedy et al., 1997; Lin and Spradling, 1997; Zhang et al., 1997; Souza et al., 1999; Olivas and Parker, 2000; Parisi and Lin, 2000; Nakahata et al., 2001; Tadauchi et al., 2001; Crittenden et al., 2002) . The C-terminal RNA-biding domain is composed of eight tandem repeats, known collectively as the Pumilio homology domain (Zamore et al., 1997; Sonoda and Wharton, 1999; Wang et al., 2002) . This domain binds to a conserved consensus 8 nt binding motif [UGUA(A/U/C)AUA ] known as the NRE (White et al., 2001) or Pumilio-binding element (Richter, 2010) . This highly characteristic sequence has been found in the 3Ј UTRs of many, but not all, mRNA targets of Pum . We identified a characteristic 8 nt motif (UGUAAAUA) within the ORF of Na V 1.6. This mirrors the location of an identical NRE in the DmNa v transcript (Muraro et al., 2008) . The presence of an NRE in Na v 1.6 supports our hypothesis that Pum2 is able to bind the transcript of this gene (the predominant Na V in mammalian visual cortical neurons). Our analysis of other Na v s (our unpublished data) show NREs to be additionally present in Na v 1.1, Na v 1.2, and Na v 1.7 indicative of wide-scale regulation by Pum2. Pum2 immunoprecipitation has been reported to pull down Na v 1.1 from rat brain (Vessey et al., 2010) .
If Pum2 and its targets are widely expressed, then how is celltype-specific regulation achieved? The answer to this question may be reliant on cofactors. For example, Muraro et al. (2008) show that, in Drosophila CNS, the effect of Pum in regulating I Na requires the cofactor brain tumor (Brat) in some, but not all, neuron types . Equally, translational repression of cyclin B requires the established cofactor Nanos but not Brat, whereas translational repression of hunchback absolutely requires both cofactors (Sonoda and Wharton, 1999). In mammalian neurons, the requirement for these cofactors in Pum2-dependent translational repression of Na v s is unknown. Moreover, there are several human homologs of Nanos, termed Nanos 1-3, that are located on chromosomes 10q26. 11, 19q13.32, and 19p13.13, respectively (Haraguchi et al., 2003) . The potential cofactor Brat is also present in variant copies, termed tripartite motif protein 2 (TRIM2), TRIM3, and TRIM32 located on chromosomes 4q31.3, 11p15.5, and 9q33.1, respectively (El-Husseini et al., 2001; Reymond et al., 2001; Frosk et al., 2002; Sardiello et al., 2008) . Few studies have investigated the role of either Nanos or TRIM proteins in mammalian CNS. Perhaps surprisingly, although Nanos1 mRNA has been observed in pyramidal cells of the hippocampus (Haraguchi et al., 2003) and human Nanos1 protein interacts with human Pum2 in a stable complex in germ-line stem cells (Jaruzelska et al., 2003) , Nanos1 knock-out mice show no significant neural defects in terms of their behavior (Haraguchi et al., 2003) . This observation was puzzling, because studies in Drosophila show a clear requirement for Nanos in Pum-dependent transitional repression of a range of CNS genes, including DmNa v and eIF-4e (Menon et al., 2004; Muraro et al., 2008) . However, genetic redundancy may mask any effects of deleting a single Nanos gene in mammals. The simpler genome of Drosophila often negates redundancy and in this instance presents the opportunity to further investigate Pum-dependent homeostasis, reassured by the knowledge that a similar, if not identical, mechanism operates in mammalian brain.
An important question that remains unanswered is how synaptic depolarization at the membrane is transduced to activate homeostatic mechanisms. High-frequency burst activity is sufficient to evoke long-term potentiation of intrinsic excitability in layer V pyramidal neurons. This effect is dependent on an influx of extracellular Ca 2ϩ and, moreover, can be mimicked by activation of protein kinase A (Cudmore and Turrigiano, 2004). Similarly, a reduction in action potential firing in cultured hippocampal pyramidal neurons, attributable to KCl-induced depolarization, is prevented by the presence of an L-type Ca 2ϩ channel blocker but not by antagonism of NMDA receptors (O'Leary et al., 2010) . These, and other studies highlight intracellular Ca 2ϩ levels as a possible sensor of membrane depolarization (Günay and Prinz, 2010) . Changes in gene expression in neurons resulting from activity-mediated Ca 2ϩ entry have been extensively described, but no obvious candidates have yet emerged that might link activity to a specific homoestatic response (Miyamoto, 2006) . It is also questionable whether a change of I Na density alone is sufficient to alter membrane excitability in the manner reported in this and many other studies: increasing depolarization causing a reduction in I Na and vice versa. Indeed, in a recent modeling study, it was shown that increasing I Na alone unexpectedly reduces firing rate in response to high input current. Only at low current input did the model neurons respond by firing more action potentials (Kispersky et al., 2012) . Thus, as shown by Desai et al. (1999) , homeostasis likely involves a coordinated alteration of multiple ionic conductances to effect the desired change to membrane excitability. Of course, additional mechanisms probably contribute to activity-dependent homeostasis. For example, chronic depolarization of cultured hippocampal neurons is sufficient to reduce action potential threshold by causing a distal translocation of the AIS away from the soma, an effect that is reversible on returning to normal activity conditions (Grubb and Burrone, 2010a,b) .
In summary, we show that activity-dependent regulation of intrinsic excitability in mammalian cortical pyramidal neurons requires Pum2-dependent translational regulation of Na V 1.6 mRNA and that Pum2 is an essential component of the homeo-
